Based on metabonomics to discuss the treatment of refractory gout from 'Yin Fire' theory

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100043277

Enrollment

Unknown

Registered

2021-02-09

Start date

2021-03-01

Completion date

Unknown

Last updated

2021-06-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Refractory gout

Interventions

Group C:Chinese medicine treatment group

Group D:Western medicine treatment

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) The above diagnostic criteria were met. (2) They were 18-70 years old. (3) In the acute stage, the patients were treated with conventional western medicine, non steroidal anti-inflammatory analgesics and 5 days of treatment. (4) Good compliance, can receive treatment and testing according to the standard.

Exclusion criteria

Exclusion criteria: Pregnant or lactating women and psychiatric patients; patients with endocrine diseases; patients with severe malnutrition or severe damage to heart, brain, kidney and hematopoietic system; patients with other rheumatic diseases. Can not cooperate with the research process.

Design outcomes

Primary

Measure	Time frame
Metabonomics;	—

Countries

Cina

Contacts

Public ContactJianhong Peng

Dongguan Hospital of Traditional Chinese Medicine

925294293@qq.com+86 13538353635

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026